Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients

por Wang, Xi, Ring, Brian Z., Seitz, Robert S., Ross, Douglas T., Woolf, Kirsten, Beck, Rodney A., Hicks, David G., Yeh, Shuyuan
Publicado 2015

TLE3 as a candidate biomarker of response to taxane therapy

por Kulkarni, Swati A, Hicks, David G, Watroba, Nancy L, Murekeyisoni, Christine, Hwang, Helena, Khoury, Thaer, Beck, Rodney A, Ring, Brian Z, Estopinal, Noel C, Schreeder, Marshall T, Seitz, Robert S, Ross, Douglas T
Publicado 2009

Mammostrat(® )as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy

por Bartlett, John MS, Thomas, Jeremy, Ross, Douglas T, Seitz, Robert S, Ring, Brian Z, Beck, Rodney A, Pedersen, Hans Christian, Munro, Alison, Kunkler, Ian H, Campbell, Fiona M, Jack, Wilma, Kerr, Gillian R, Johnstone, Laura, Cameron, David A, Chetty, Udi
Publicado 2010

The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence

por Hicks, David G, Janarthanan, Bagi R, Vardarajan, Ramya, Kulkarni, Swati A, Khoury, Thaer, Dim, Daniel, Budd, G Thomas, Yoder, Brian J, Tubbs, Raymond, Schreeder, Marshall T, Estopinal, Noel C, Beck, Rodney A, Wang, Yanling, Ring, Brian Z, Seitz, Robert S, Ross, Douglas T
Publicado 2010